Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (191-200 of 536) with videos related to

Pageof 54
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell TransplantationMonzr M Al Malki, Joo Y Song, Dongyun Yang, et al.
British Journal of Haematology|February 26, 2013
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adultsChristine L Phillips, Stella M Davies, Richard McMasters, et al.
Blood|October 11, 2007
Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesisAnna M Eiring, Paolo Neviani, Ramasamy Santhanam, et al.
Leukemia & Lymphoma|February 29, 2012
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B studyGerard Lozanski, Amy S Ruppert, Nyla A Heerema, et al.
Leukemia & Lymphoma|December 9, 2021
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantationAmandeep Salhotra, Dongyun Yang, Sally Mokhtari, et al.
Cancer|October 28, 2023
A phase 1 trial of 8-chloro-adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokineticsVinod Pullarkat, Lisa S Chen, Joycelynne Palmer, et al.
Nature Communications|April 28, 2026
Generation of mixed-valency, modular multispecific antibodies using disulfide-linked Fc-FcγR complexesMiso Park, Kevin Ly, Bea Parcutela, et al.
British Journal of Haematology|May 29, 2024
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemiaTamer Othman, Paul Koller, Hoda Pourhassan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B StudyGuido Marcucci, Kati Maharry, Susan P Whitman, et al.
Journal of Cellular Physiology|February 23, 2019
Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesisDang Quan Nguyen, Dinh Hoa Hoang, Thanh Thao Vo Nguyen, et al.
Pageof 54

Showing results (191-200 of 536) with videos related to

Sort By:
Pageof 54
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell TransplantationMonzr M Al Malki, Joo Y Song, Dongyun Yang, et al.
British Journal of Haematology|February 26, 2013
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adultsChristine L Phillips, Stella M Davies, Richard McMasters, et al.
Blood|October 11, 2007
Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesisAnna M Eiring, Paolo Neviani, Ramasamy Santhanam, et al.
Leukemia & Lymphoma|February 29, 2012
Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B studyGerard Lozanski, Amy S Ruppert, Nyla A Heerema, et al.
Leukemia & Lymphoma|December 9, 2021
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantationAmandeep Salhotra, Dongyun Yang, Sally Mokhtari, et al.
Cancer|October 28, 2023
A phase 1 trial of 8-chloro-adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokineticsVinod Pullarkat, Lisa S Chen, Joycelynne Palmer, et al.
Nature Communications|April 28, 2026
Generation of mixed-valency, modular multispecific antibodies using disulfide-linked Fc-FcγR complexesMiso Park, Kevin Ly, Bea Parcutela, et al.
British Journal of Haematology|May 29, 2024
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemiaTamer Othman, Paul Koller, Hoda Pourhassan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B StudyGuido Marcucci, Kati Maharry, Susan P Whitman, et al.
Journal of Cellular Physiology|February 23, 2019
Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesisDang Quan Nguyen, Dinh Hoa Hoang, Thanh Thao Vo Nguyen, et al.
Pageof 54